Genomenon last raised $5.5M in its Early Stage VC (May 2024).
- ·The complete investor list: 25 names
- ·Watch Genomenon: the Monday email on marks, rounds and moves
Genomenon funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2024 | Early Stage VC | $5.5M | ▮ | ▮ |
| Feb 2022 | Early Stage VC | $20.0M | ▮ | ▮ |
| May 2020 | Seed Round | $2.9M | ▮ | ▮ |
| Aug 2015 | Seed Round | $446K | ▮ | ▮ |
Membership and data by Private Market View
Genomenon valuation
Genomenon's last known valuation is $68 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Genomenon raised?
Genomenon has raised $36.8 million across 4 recorded rounds since 2015. The largest was a $5.5 million early-stage round in May 2024.
Genomenon has filed 4 Form Ds with the SEC since 2015, most recently in May 2024 ($5.5 million sold to 30 investors).
How Genomenon's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Genomenon, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Genomenon
- What is Genomenon worth?
- Genomenon's last known valuation is $68.0M.
- How much has Genomenon raised?
- Genomenon has raised $36.8M in total funding across 4 recorded rounds.
- When did Genomenon last raise?
- Genomenon last raised in May 2024 (Early Stage VC), raising $5.5M.